 | Panic DisorderJuly 2006; updated July 2007 | Background | | Panic disorder is persistent fear that interferes with the ability to conduct activities
of daily living. A patient is diagnosed as having panic disorder when he or she has
experienced 4 panic attacks within a 4-week period, or at least 1 panic attack followed
by a month of persistent fear. Panic attacks are discrete, sudden-onset episodes of
intense fear or apprehension accompanied by specific somatic or psychiatric symptoms
(eg, palpitations, shortness of breath, or fear of losing control). Patients may associate panic attacks with various activities, such as leaving home,
driving, and even visiting health care providers for medical appointments. The symptoms
of panic disorder usually begin in late adolescence to the mid-30s and may coincide with
the presentation of major depressive disorder, social phobia, or generalized anxiety
disorder. Symptoms may mimic physical illness. Patients with panic disorder have an
increased incidence of suicide. | |
| SOAP (Subjective, Objective, Assessment, Plan) | | | Subjective | | The patient complains of panic attacks, or describes episodes of:  | Chest pain or discomfort | | | Depersonalization or derealization | | | Dizziness, lightheadedness, faintness, or feeling of unsteadiness | | | Fear of dying | | | Fear of going crazy or losing control | | | Hot flashes or chills | | | Nausea or abdominal distress | | | Numbness or tingling sensations | | | Palpitations or accelerated heart rate | | | Sensation of choking | | | Shortness of breath or smothering sensation | | | Sweating | | | Trembling or shaking | |
In the absence of physical causes, 4 or more of the above symptoms accompanying
multiple panic attacks are diagnostic of panic disorder. Panic attacks are, by
definition, self-limited and they peak quickly, usually within 10 minutes. Symptoms
that persist continuously for longer periods suggest other causes. | History | | Inquire about the following: | Any associated or concurrent symptoms, such as rash, cough, or fever | | | Current medications, herbal products, and supplements | | | Family history of mood and psychiatric illnesses, particularly anxiety and
panic | | | Frequency, duration, and onset of panic episodes | | | Any relationship to food or hunger | | | Settings in which attacks occur to determine whether there are triggers,
such as being outdoors (agoraphobia) | | | Intake of caffeine, recreational drugs, and alcohol (current and recent) | | | New onset versus previous incidents | | | Sleep disturbances | | | Concomitant illnesses | |
| |
| |
| Objective | | Perform a complete physical examination, including vital signs and thyroid, cardiac,
pulmonary, and neurologic evaluation. During actual panic attacks, patients may have an increased heart rate or respiratory
rate. | |
| Plan | | | Treatment | | Once other diagnoses have been ruled out, consider the following treatments: | Pharmacotherapy | | Patients with advanced HIV disease, like geriatric patients, may become more
vulnerable to the central nervous system (CNS) effects of certain
medications. Medications that affect the CNS should be started at low doses
and should be titrated slowly. Similar precautions should apply to patients
with liver dysfunction. Some interactions occur between selective serotonin reuptake inhibitors
(SSRIs), benzodiazepines, and HIV medications. Consult with an HIV expert or
pharmacist before prescribing. Treatment should be continued for at least 6 months beyond the resolution of
symptoms. | |
| Options | | | SSRI-type antidepressants, including fluoxetine (Prozac), paroxetine
(Paxil), sertraline (Zoloft), citalopram (Celexa), and escitalopram
(Lexapro) may be effective. Venlafaxine timed-release formulation
(Effexor XR), at a dosage of 75-225 mg/d, has been approved for the
treatment of generalized anxiety disorder. There is a risk of
hypertension at the higher dosages of venlafaxine; monitor blood
pressure. | | | Tricyclic antidepressants may be used at low doses, including
nortriptyline (Pamelor), 10-75 mg at bedtime; desipramine (Norpramin),
10-50 mg daily; amitriptyline (Elavil), 25-75 mg at bedtime; and
imipramine (Tofranil), 25-75 mg at bedtime. Doses should be titrated
slowly. Tricyclic antidepressants may reach higher blood concentrations
when coadministered with certain protease inhibitors, including
ritonavir (contained in Kaletra); consult with an HIV expert or
pharmacist. | | | Many patients will require initial short-term treatment with
benzodiazepines, which are titrated downward as the antidepressant is
titrated upward. Benzodiazepines should be used only for acute,
short-term management, because of the risks of tolerance and physiologic
dependence. These risks are more problematic in patients with a history
of addiction. Note that protease inhibitors and nonnucleoside reverse
transcriptase inhibitors may raise blood concentrations of many
benzodiazepines. If benzodiazepines are used, they should be started at
low doses, and other CNS depressants should be avoided. Consult with a
clinical pharmacist before prescribing. | | | Note that midazolam (Versed) and triazolam (Halcion) are
contraindicated with all protease inhibitors and with delavirdine
and efavirenz. | |
| |
| |
| |
| |
| Patient Education | | |
| Behavioral interventions can help to reduce the frequency and severity of panic
attacks. Patients should seek help from a therapist, an experienced source, or a
friend. | | | Some patients develop problems with sexual function because of the medications.
Patients should report any problems to their prescribers. | |
|
|
| |
| References | | | The appearance of external hyperlinks does not constitute endorsement by the Department of Veterans Affairs of the linked Web sites, or the information, products or services contained therein. | | |
| |
| | | |
